{"id":"https://genegraph.clinicalgenome.org/r/c49974fc-b5c8-4eaa-866d-f0d9f684757ev2.0","type":"EvidenceStrengthAssertion","dc:description":"The relationship between SLC52A3 and autosomal recessive Brown-Vialetto-Van Laere syndrome (BVVL) was evaluated using the ClinGen Clinical Validity Framework as of 9/12/2018. Variants in SLC52A3 were first reported in humans with this disease as early as 2010 (Green et al., PMID 20206331). SLC52A3 is associated with the childhood onset neurodegenerative syndrome Brown–Vialetto–Van Laere (BVVL) which is characterized by sensorineural hearing loss and ponto-bulbar palsy (PMID: 26976849, 30420458). Whilst these are the most common clinical features, BVVL can also present without either symptom (PMID: 26973221). The standard treatment for BVVL is riboflavin supplementation which is associated with favourable clinical outcomes (PMID: 26973221). At least 25 variants (e.g. missense, in-frame indel, nonsense, frameshift) have been reported in humans. Evidence supporting this gene-disease relationship includes case-level data, case-control data, segregation data, and mouse models, a drosophila model, biochemical function studies implicating the gene's role in riboflavin uptake, and functional alteration studies showing that alteration to the gene impairs riboflavin uptake which appears to be the mechanism for disease. Variants in this gene have been reported in at least 22 probands in 5 publications (PMIDs: 29053833, 25462087, 21110228, 20206331, 22824638). Variants in this gene segregated with disease in 2 additional family members. In summary, SLC52A3 is definitively associated with autosomal recessive Brown-Vialetto-Van Laere syndrome. This has been repeatedly demonstrated in both the research and clinical diagnostic settings, and has been upheld over time. \n\n\nThis gene-disease pair was originally evaluated by the ClinGen Hearing Loss GCEP on 9/18/2018. It was reevaluated on 6/21/2023 in collaboration with the Amyotrophic Lateral Sclerosis Spectrum Disorders GCEP. As a result of this reevaluation, the classification did not change. However, scoring was adjusted to the current Gene Clinical Validity SOP Version 9. It is also worth highlighting that in the mouse and drosophila models (PMID: 27272163, 29053833) riboflavin supplementation was able to restore normal function and replicates the rescue of the phenotypes observed in humans with Brown-Vialetto-Van Laere syndrome (PMID: 30420458).\n","dc:isVersionOf":"https://genegraph.clinicalgenome.org/r/c49974fc-b5c8-4eaa-866d-f0d9f684757e","GCISnapshot":"https://genegraph.clinicalgenome.org/r/b0ae82e2-4c39-45b2-ba2d-6fe2570dbcfc","calculatedEvidenceStrength":"Definitive","changes":[{"id":"cg:sopChange"},{"id":"cg:summaryChange"},{"id":"cg:otherTextChange"}],"contributions":[{"agent":"https://genegraph.clinicalgenome.org/agent/10096","role":"SecondaryContributor"},{"id":"https://genegraph.clinicalgenome.org/r/b0ae82e2-4c39-45b2-ba2d-6fe2570dbcfc_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10007","date":"2023-09-04T16:00:00.000Z","role":"Approver"},{"id":"https://genegraph.clinicalgenome.org/r/b0ae82e2-4c39-45b2-ba2d-6fe2570dbcfc_publish_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10007","date":"2023-10-10T14:39:01.791Z","role":"Publisher"}],"curationReasons":["RecurationTiming"],"evidence":[{"id":"https://genegraph.clinicalgenome.org/r/b0ae82e2-4c39-45b2-ba2d-6fe2570dbcfc_overall_genetic_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/216fdb0a-f076-4bec-91a0-d9a30df22f02_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/216fdb0a-f076-4bec-91a0-d9a30df22f02","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/29053833","rdfs:label":"Manole AM1 (English)","ageType":"AgeAtDiagnosis","ageUnit":"Years","ageValue":22,"allele":[{"id":"https://genegraph.clinicalgenome.org/r/6f42bd9f-e159-4b06-b1ec-0b00c9278247","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"XM_011529148.1(SLC52A3):c.1074G>A (p.Arg358=)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA509341507"}},{"id":"https://genegraph.clinicalgenome.org/r/fbbc6ea8-be34-47dc-a517-f43de49a7f75","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"XM_011529148.1(SLC52A3):c.352G>A (p.Val118Met)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA407964017"}}],"detectionMethod":"PCR and sanger sequencing of SLC52A2, SLC52A1 and SLC52A3 \n","firstTestingMethod":"PCR","phenotypeFreeText":"sensorineural hearing loss presenting feature at 2 years, optic atrophy, breathing difficulty, gastronomy only feeding","secondTestingMethod":"Sanger sequencing","sex":"Male","variant":[{"id":"https://genegraph.clinicalgenome.org/r/c1342729-b688-4ed5-b0c4-dc9e8a8661b4_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/29053833","allele":{"id":"https://genegraph.clinicalgenome.org/r/6f42bd9f-e159-4b06-b1ec-0b00c9278247"},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}},{"id":"https://genegraph.clinicalgenome.org/r/1f9828a5-094a-483d-8e74-0d4ef9953e45_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/29053833","allele":{"id":"https://genegraph.clinicalgenome.org/r/fbbc6ea8-be34-47dc-a517-f43de49a7f75"},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}]},{"id":"https://genegraph.clinicalgenome.org/r/1f9828a5-094a-483d-8e74-0d4ef9953e45","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/1f9828a5-094a-483d-8e74-0d4ef9953e45_variant_evidence_item"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/c1342729-b688-4ed5-b0c4-dc9e8a8661b4","type":"EvidenceLine","dc:description":"SpliceAi score 0.03 for synonymous variant\n","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/c1342729-b688-4ed5-b0c4-dc9e8a8661b4_variant_evidence_item"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/ca7cd5e6-7e95-405a-bc8d-44f74c572d8f_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/ca7cd5e6-7e95-405a-bc8d-44f74c572d8f","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/25462087","rdfs:label":"Cosgrove Proband compound het","ageType":"AgeAtReport","ageUnit":"Years","ageValue":27,"allele":[{"id":"https://genegraph.clinicalgenome.org/r/0be11801-9d91-42d0-8326-a72c64bb84fd","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"XM_011529148.1(SLC52A3):c.383C>T (p.Pro128Leu)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA310679172"}},{"id":"https://genegraph.clinicalgenome.org/r/19d769af-fb86-48f4-b578-6273412e8602","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"XM_011529148.1(SLC52A3):c.1292G>A (p.Trp431Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA407961938"}}],"detectionMethod":"\"genetic testing for BVVL - sequencing\"","firstTestingMethod":"Other","phenotypeFreeText":"progressive hearing loss developed age 26.5, bilateral facial weakness, subtle tongue wasting and hypophonic speech, rapid involuntary horizontal and vertical eye movements consistent with opsoclonus. two month history of progressive bulbar dysfunction","sex":"Female","variant":[{"id":"https://genegraph.clinicalgenome.org/r/c066142c-2d2a-40f6-aec7-b682d223b59f_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/25462087","allele":{"id":"https://genegraph.clinicalgenome.org/r/19d769af-fb86-48f4-b578-6273412e8602"},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}},{"id":"https://genegraph.clinicalgenome.org/r/ddfd85e8-301d-4367-8ef8-8b7b23456c0c_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/25462087","allele":{"id":"https://genegraph.clinicalgenome.org/r/0be11801-9d91-42d0-8326-a72c64bb84fd"},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}]},{"id":"https://genegraph.clinicalgenome.org/r/ddfd85e8-301d-4367-8ef8-8b7b23456c0c","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/ddfd85e8-301d-4367-8ef8-8b7b23456c0c_variant_evidence_item"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/c066142c-2d2a-40f6-aec7-b682d223b59f","type":"EvidenceLine","dc:description":"Downgraded for non-NMD","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/c066142c-2d2a-40f6-aec7-b682d223b59f_variant_evidence_item"}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":0.6},{"id":"https://genegraph.clinicalgenome.org/r/e211b2e3-7f88-468b-892e-4e8e2ec278b0_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/e211b2e3-7f88-468b-892e-4e8e2ec278b0","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/20206331","rdfs:label":"Green Case 4 European/Asian","ageType":"AgeAtOnset","ageUnit":"Months","ageValue":9,"allele":[{"id":"https://genegraph.clinicalgenome.org/r/8fa3a53f-e9ef-4cef-8d59-a84ff1f26f72","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_033409.4(SLC52A3):c.639C>G (p.Tyr213Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/210018"}},{"id":"https://genegraph.clinicalgenome.org/r/c342840e-f8dc-4600-b429-0899ff789bfb","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_033409.4(SLC52A3):c.211G>A (p.Glu71Lys)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA346975"}}],"detectionMethod":"Sequencing of several genes in region see other cases in this publication.","firstTestingMethod":"Sanger sequencing","phenotypeFreeText":"breathing problems at age 9 mo, respiratory compromise at ae 2, multiple cranial nerve involvement, died at age 2","phenotypes":"obo:HP_0002098","sex":"Male","variant":[{"id":"https://genegraph.clinicalgenome.org/r/cf40f134-7ee2-4103-9692-bc752f91a419_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/20206331","allele":{"id":"https://genegraph.clinicalgenome.org/r/c342840e-f8dc-4600-b429-0899ff789bfb"},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}},{"id":"https://genegraph.clinicalgenome.org/r/e0c3b9fd-601b-4950-92b4-f15a46f91fda_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/20206331","allele":{"id":"https://genegraph.clinicalgenome.org/r/8fa3a53f-e9ef-4cef-8d59-a84ff1f26f72"},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}]},{"id":"https://genegraph.clinicalgenome.org/r/e0c3b9fd-601b-4950-92b4-f15a46f91fda","type":"EvidenceLine","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/e0c3b9fd-601b-4950-92b4-f15a46f91fda_variant_evidence_item"}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/cf40f134-7ee2-4103-9692-bc752f91a419","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/cf40f134-7ee2-4103-9692-bc752f91a419_variant_evidence_item"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":1.6},{"id":"https://genegraph.clinicalgenome.org/r/74b00824-fdc3-4034-96b9-08e312465a28_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/74b00824-fdc3-4034-96b9-08e312465a28","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/29053833","rdfs:label":"Manole AM2 (English)","allele":[{"id":"https://genegraph.clinicalgenome.org/r/0585faa2-406c-4cdc-a1e2-7b2923a13afc","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"XM_011529148.1(SLC52A3):c.1128_1129insT (p.Asn377Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA658820920"}},{"id":"https://genegraph.clinicalgenome.org/r/c45ab46b-7260-474e-b103-c322938d0a92","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_033409.4(SLC52A3):c.1293G>A (p.Trp431Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA16609696"}}],"detectionMethod":"\nPCR and sanger sequencing of SLC52A2, SLC52A1 and SLC52A3 \n","firstTestingMethod":"PCR","phenotypeFreeText":"horizontal nystagmus, ptosis neck weakness 8 mo onset, optic atrophy, No hearing loss, sonsorimotor neuropathy, completely paralysed, ventilator dependent, died at age 2","secondTestingMethod":"Sanger sequencing","sex":"Male","variant":[{"id":"https://genegraph.clinicalgenome.org/r/dbd5c4d7-361f-472f-9f48-8034f6782b41_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/29053833","allele":{"id":"https://genegraph.clinicalgenome.org/r/0585faa2-406c-4cdc-a1e2-7b2923a13afc"},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}},{"id":"https://genegraph.clinicalgenome.org/r/1d3e6676-74a6-47b7-b132-4c8dfdc02bba_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/29053833","allele":{"id":"https://genegraph.clinicalgenome.org/r/c45ab46b-7260-474e-b103-c322938d0a92"},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}]},{"id":"https://genegraph.clinicalgenome.org/r/1d3e6676-74a6-47b7-b132-4c8dfdc02bba","type":"EvidenceLine","dc:description":"Downgraded for non-NMD variant","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/1d3e6676-74a6-47b7-b132-4c8dfdc02bba_variant_evidence_item"}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/dbd5c4d7-361f-472f-9f48-8034f6782b41","type":"EvidenceLine","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/dbd5c4d7-361f-472f-9f48-8034f6782b41_variant_evidence_item"}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1.5}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":2.0},{"id":"https://genegraph.clinicalgenome.org/r/1fa47b7c-6f2c-43c4-94b6-420d3c719a58_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/1fa47b7c-6f2c-43c4-94b6-420d3c719a58","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/29053833","rdfs:label":"Manole AM4 (English)","ageType":"AgeAtDiagnosis","ageUnit":"Years","ageValue":19,"allele":[{"id":"https://genegraph.clinicalgenome.org/r/cdd8b951-81eb-45d9-ad09-bee2cc23bfd6","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"XM_011529148.1(SLC52A3):c.1253G>A (p.Gly418Asp)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA407962017"}},{"id":"https://genegraph.clinicalgenome.org/r/be51b235-cb32-41a7-b111-ba6864c78a62","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"XM_011529148.1(SLC52A3):c.37G>A (p.Gly13Arg)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA9724838"}}],"detectionMethod":"\nPCR and sanger sequencing of SLC52A2, SLC52A1 and SLC52A3 \n","firstTestingMethod":"PCR","phenotypeFreeText":"sensorineural hearing loss presenting features onset 8 years, optic atrophy, mild postural tremor, compromisd, chewing difficulties","secondTestingMethod":"Sanger sequencing","sex":"Male","variant":[{"id":"https://genegraph.clinicalgenome.org/r/4ec3143e-1377-4e15-be31-8d537fe3a60d_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/29053833","allele":{"id":"https://genegraph.clinicalgenome.org/r/cdd8b951-81eb-45d9-ad09-bee2cc23bfd6"},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}},{"id":"https://genegraph.clinicalgenome.org/r/35b765d9-e317-44e6-86bf-7856ff9584d8_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/29053833","allele":{"id":"https://genegraph.clinicalgenome.org/r/be51b235-cb32-41a7-b111-ba6864c78a62"},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}]},{"id":"https://genegraph.clinicalgenome.org/r/4ec3143e-1377-4e15-be31-8d537fe3a60d","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/4ec3143e-1377-4e15-be31-8d537fe3a60d_variant_evidence_item"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/35b765d9-e317-44e6-86bf-7856ff9584d8","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/35b765d9-e317-44e6-86bf-7856ff9584d8_variant_evidence_item"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":0.2},{"id":"https://genegraph.clinicalgenome.org/r/81acc6c9-3e58-41f3-bc24-53c3b99529dd_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/81acc6c9-3e58-41f3-bc24-53c3b99529dd","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/20206331","rdfs:label":"Family 5 Case 7 (Pakistani)","ageType":"AgeAtOnset","ageUnit":"Years","ageValue":5,"allele":{"id":"https://genegraph.clinicalgenome.org/r/cdbe82f8-8c66-46c6-95ed-9b34f5379c7f","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_033409.4(SLC52A3):c.670T>C (p.Phe224Leu)","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/142"}},"detectionMethod":"sequencing of SLC52A3","firstTestingMethod":"PCR","phenotypeFreeText":"tonge fasciculations, facialpalsy (5 yr age of onset), defaness at age 7, respiratory compromise at age 13, Progressive muscle weakness and wasting external opthalmoplegia, died at age 14 yr.","sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/a10d8ef1-2426-4d89-b0c4-fad985b88bb6_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/20206331","allele":{"id":"https://genegraph.clinicalgenome.org/r/cdbe82f8-8c66-46c6-95ed-9b34f5379c7f"},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}},{"id":"https://genegraph.clinicalgenome.org/r/a10d8ef1-2426-4d89-b0c4-fad985b88bb6","type":"EvidenceLine","dc:description":"Technically should be scored a total of 0.1 due to consanguinity.","calculatedScore":0.2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/a10d8ef1-2426-4d89-b0c4-fad985b88bb6_variant_evidence_item"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.2}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":0.2},{"id":"https://genegraph.clinicalgenome.org/r/1aaa61cd-42f4-4e78-91af-11d7c804942c_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/1aaa61cd-42f4-4e78-91af-11d7c804942c","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/20206331","rdfs:label":"Family 7 Case 9 (European)","allele":[{"id":"https://genegraph.clinicalgenome.org/r/4c0baada-8043-4f8c-ae15-565c04372b36","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_033409.4(SLC52A3):c.1238T>C (p.Val413Ala)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA339797"}},{"id":"https://genegraph.clinicalgenome.org/r/08b323b1-7899-4095-acd9-2ee34b57fcf6","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_033409.4(SLC52A3):c.106G>A (p.Glu36Lys)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA339796"}}],"detectionMethod":"SLC52A3 sequencing","firstTestingMethod":"Sanger sequencing","phenotypeFreeText":"onset in the second decade of life, multiple peripheral neuropathy, deafness, NO respiratory compromise, progressive weakness, muscle wasting and truncal ataxia. alive age 57","sex":"Male","variant":[{"id":"https://genegraph.clinicalgenome.org/r/cf74e7b2-3369-4e28-a7e9-9d8166d93fb3_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/20206331","allele":{"id":"https://genegraph.clinicalgenome.org/r/4c0baada-8043-4f8c-ae15-565c04372b36"},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}},{"id":"https://genegraph.clinicalgenome.org/r/c6cadd31-7f05-4b90-b8ca-011670662331_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/20206331","allele":{"id":"https://genegraph.clinicalgenome.org/r/08b323b1-7899-4095-acd9-2ee34b57fcf6"},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}]},{"id":"https://genegraph.clinicalgenome.org/r/cf74e7b2-3369-4e28-a7e9-9d8166d93fb3","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/cf74e7b2-3369-4e28-a7e9-9d8166d93fb3_variant_evidence_item"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/c6cadd31-7f05-4b90-b8ca-011670662331","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/c6cadd31-7f05-4b90-b8ca-011670662331_variant_evidence_item"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":0.2},{"id":"https://genegraph.clinicalgenome.org/r/31876980-c9db-4bf3-a0e4-37477ee4199a_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/31876980-c9db-4bf3-a0e4-37477ee4199a","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/21110228","rdfs:label":"Bosch Patient 3","ageType":"AgeAtReport","ageUnit":"Years","ageValue":7,"allele":[{"id":"https://genegraph.clinicalgenome.org/r/322694e5-94ae-40a8-919d-1088a8d292ea","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_033409.4(SLC52A3):c.49T>C (p.Trp17Arg)","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/210011"}},{"id":"https://genegraph.clinicalgenome.org/r/8fa3a53f-e9ef-4cef-8d59-a84ff1f26f72"}],"detectionMethod":"PCR\n\nSequencing of the ETFDH, ETFA, ETFB genes and SLC52A3\u000b\n","firstTestingMethod":"PCR","phenotypeFreeText":"Clinical diagnosis of Brown-Violetto-Van Laere syndrome, feeding problems, slow motor development, onset of 5 months for generalized muscle weakness, respiratory insufficiency, severe sensorineural hearing loss, palsies of the 7th and 12th cranial nerves","sex":"Female","variant":[{"id":"https://genegraph.clinicalgenome.org/r/aa944e09-6ef2-469f-b679-83c545a6434d_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/21110228","allele":{"id":"https://genegraph.clinicalgenome.org/r/8fa3a53f-e9ef-4cef-8d59-a84ff1f26f72"},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}},{"id":"https://genegraph.clinicalgenome.org/r/9b90b72b-8181-447c-9b44-f0472d01782d_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/21110228","allele":{"id":"https://genegraph.clinicalgenome.org/r/322694e5-94ae-40a8-919d-1088a8d292ea"},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}]},{"id":"https://genegraph.clinicalgenome.org/r/9b90b72b-8181-447c-9b44-f0472d01782d","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/9b90b72b-8181-447c-9b44-f0472d01782d_variant_evidence_item"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/aa944e09-6ef2-469f-b679-83c545a6434d","type":"EvidenceLine","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/aa944e09-6ef2-469f-b679-83c545a6434d_variant_evidence_item"}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1.5}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":1.6},{"id":"https://genegraph.clinicalgenome.org/r/1b9eae46-b790-4e5e-92a0-38a9129b79de_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/1b9eae46-b790-4e5e-92a0-38a9129b79de","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/20206331","rdfs:label":"Green Case 3 European ancestry","ageType":"AgeAtOnset","ageUnit":"Months","ageValue":16,"allele":{"id":"https://genegraph.clinicalgenome.org/r/37299bff-628b-4960-9d7c-a7f10a15a058","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_033409.4(SLC52A3):c.211G>T (p.Glu71Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/140"}},"detectionMethod":"several genes sequenced in the homozygosity region after mapping We elected to first analyze\nNRSN2 (MIM 610666), TCF15 (MIM 601010), SNPH (MIM\n604942), SDCBP2, and NSFL1C because of their high\nexpression in the brain, followed by sequencing of the\nremaining exons within the target region. Also, C20orf54 AKA SLC52A3","firstTestingMethod":"Genotyping","phenotypeFreeText":"Progressive bulbar palsy, respiratory compromise: Ventilated, over last few months, Anterior horn\nneuropathy; Intact cognitive development. Died at age < 3 years","sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/2153ec16-1e8a-46b3-998f-df88def29c71_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/20206331","allele":{"id":"https://genegraph.clinicalgenome.org/r/37299bff-628b-4960-9d7c-a7f10a15a058"},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}},{"id":"https://genegraph.clinicalgenome.org/r/2153ec16-1e8a-46b3-998f-df88def29c71","type":"EvidenceLine","calculatedScore":3.0,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/2153ec16-1e8a-46b3-998f-df88def29c71_variant_evidence_item"}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":3.0}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":3.0},{"id":"https://genegraph.clinicalgenome.org/r/b0ae82e2-4c39-45b2-ba2d-6fe2570dbcfc_seg_el","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/f38b5d4c-db1c-48f1-a669-d5c9fe1ebf91_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/20206331","rdfs:label":"Pakistani family Cases 5 + 6","family":{"id":"https://genegraph.clinicalgenome.org/r/f38b5d4c-db1c-48f1-a669-d5c9fe1ebf91","type":"Family","rdfs:label":"Pakistani family Cases 5 + 6","member":{"id":"https://genegraph.clinicalgenome.org/r/cf620d1a-1f86-40ce-861d-fec9f321f38f","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/20206331","rdfs:label":"Family 4 Case 5","allele":{"id":"https://genegraph.clinicalgenome.org/r/78c2ac82-c971-46d8-82cf-b66da16ba04d","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_033409.4(SLC52A3):c.394C>T (p.Arg132Trp)","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/141"}},"detectionMethod":"See other methods from this paper","firstTestingMethod":"Genotyping","phenotypeFreeText":"Case 5: 12 yr onset, VII nerve palsy, deafness, stridor on exercise age 28 yr, progressive muscle weakness; alive age 36\nCase 6: 12 yr onset, deafness, tongue wassting and fasciculations, 12 yr deafness, 15 yr cochlear implant, stridor on exercise age 21, poor balance, proximal muscle group weakness; alive age 29","sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/552c2992-5138-41ba-a147-7cd9850651e6_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/20206331","allele":{"id":"https://genegraph.clinicalgenome.org/r/78c2ac82-c971-46d8-82cf-b66da16ba04d"},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}}},"phenotypeFreeText":"Case 5: 12 yr onset, VII nerve palsy, deafness, stridor on exercise age 28 yr, progressive muscle weakness; alive age 36\nCase 6: 12 yr onset, deafness, tongue wassting and fasciculations, 12 yr deafness, 15 yr cochlear implant, stridor on exercise age 21, poor balance, proximal muscle group weakness; alive age 29","phenotypePositiveAllelePositive":2,"proband":{"id":"https://genegraph.clinicalgenome.org/r/cf620d1a-1f86-40ce-861d-fec9f321f38f"}},{"id":"https://genegraph.clinicalgenome.org/r/9b8e4eda-18e5-4b25-9988-00548a163b49_proband_segregation","type":"FamilyCosegregation","dc:description":"not enough affecteds","dc:source":"https://pubmed.ncbi.nlm.nih.gov/20206331","rdfs:label":"Arabic Family Green Case 1 and 2","estimatedLodScore":0.6,"family":{"id":"https://genegraph.clinicalgenome.org/r/9b8e4eda-18e5-4b25-9988-00548a163b49","type":"Family","rdfs:label":"Arabic Family Green Case 1 and 2","member":{"id":"https://genegraph.clinicalgenome.org/r/3206beac-581e-4e31-bead-559f23d5a2b8","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/20206331","rdfs:label":"Arabic Family Green","allele":{"id":"https://genegraph.clinicalgenome.org/r/c9946e9f-954a-426c-9000-a0c651a2a63c","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_033409.4(SLC52A3):c.1325_1326del (p.Leu442ArgfsTer64)","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/139"}},"detectionMethod":"The methodology used here to locate the causative\ngene: autozygosity mapping\ntogether with targeted sequencing in identifying genes in\nrare recessive disorders for which consanguineous families\nare available.","firstTestingMethod":"Sanger sequencing","phenotypeFreeText":"Case 1: Recurrent chest infections since age 4 mo, sub acute encephalopathy, respiratory compromise at age 17 mo, diagnosed with deafness at age 13 mo, Hypotonia, cerebellar signs, brisk reflexes in the lower limbs, persistent ankle clonus, stridor, EMG: bulbar palsy, anterior horn involvement; phrenic nerve denervation, auditory neuropathy","phenotypes":["obo:HP_0002783","obo:HP_0001317","obo:HP_0008947","obo:HP_0010307","obo:HP_0000399","obo:HP_0011448","obo:HP_0002395","obo:HP_0001283"],"sex":"UnknownEthnicity","variant":{"id":"https://genegraph.clinicalgenome.org/r/27ac6adc-23d2-4901-b141-8bf0fd8023db_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/20206331","allele":{"id":"https://genegraph.clinicalgenome.org/r/c9946e9f-954a-426c-9000-a0c651a2a63c"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}}},"meetsInclusionCriteria":false,"phenotypeFreeText":"Case 1: Recurrent chest infections since age 4 mo, sub acute encephalopathy, respiratory compromise at age 17 mo, diagnosed with deafness at age 13 mo, Hypotonia, cerebellar signs, brisk reflexes in the lower limbs, persistent ankle clonus, stridor, EMG: bulbar palsy, anterior horn involvement; phrenic nerve denervation, auditory neuropathy","phenotypeNegativeAlleleNegative":0,"phenotypePositiveAllelePositive":2,"proband":{"id":"https://genegraph.clinicalgenome.org/r/3206beac-581e-4e31-bead-559f23d5a2b8"}}],"specifiedBy":"GeneValiditySegregationEvidenceCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/e4c7f483-640f-4b6f-bc38-7e4c967c1e56_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/e4c7f483-640f-4b6f-bc38-7e4c967c1e56","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/22824638","rdfs:label":"Ciccolella Patient 1","ageType":"AgeAtOnset","ageUnit":"Years","ageValue":9,"allele":[{"id":"https://genegraph.clinicalgenome.org/r/e0012f51-7b65-4efd-9ff7-a52908dd147e","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_033409.4(SLC52A3):c.796C>T (p.Arg266Trp)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA346983"}},{"id":"https://genegraph.clinicalgenome.org/r/a439e884-3ddb-4e90-a95d-54985432570a","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_033409.4(SLC52A3):c.955C>T (p.Pro319Ser)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA346987"}}],"detectionMethod":"PCR - Screened for SLC52A1, SLC52A3 and SLC52A2 variants\n\n","firstTestingMethod":"PCR","phenotypeFreeText":"bulbar palsy, distal weakness onset 10 years, facial weakness onset 9 year, Dysphagia onset 9 year, dysphonia severe 9 year onset, tonge fasciculation/atrophy, gatrostomy, tracheostomy, deafness","sex":"Male","variant":[{"id":"https://genegraph.clinicalgenome.org/r/6212b14b-89da-408f-a502-ea0e9d2691fe_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/22824638","allele":{"id":"https://genegraph.clinicalgenome.org/r/a439e884-3ddb-4e90-a95d-54985432570a"},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}},{"id":"https://genegraph.clinicalgenome.org/r/3ae575de-65ec-43e5-be80-687f818d7a5d_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/22824638","allele":{"id":"https://genegraph.clinicalgenome.org/r/e0012f51-7b65-4efd-9ff7-a52908dd147e"},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}]},{"id":"https://genegraph.clinicalgenome.org/r/3ae575de-65ec-43e5-be80-687f818d7a5d","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/3ae575de-65ec-43e5-be80-687f818d7a5d_variant_evidence_item"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/6212b14b-89da-408f-a502-ea0e9d2691fe","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/6212b14b-89da-408f-a502-ea0e9d2691fe_variant_evidence_item"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":0.2},{"id":"https://genegraph.clinicalgenome.org/r/771ba9e3-5fd3-4158-9426-a0833610b2f2_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/771ba9e3-5fd3-4158-9426-a0833610b2f2","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/29053833","rdfs:label":"Manole AM7 (Arab)","ageType":"AgeAtOnset","ageUnit":"Years","ageValue":14,"allele":{"id":"https://genegraph.clinicalgenome.org/r/26649345-4e66-43f7-86c8-e1508cd510d7","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_033409.4(SLC52A3):c.634C>T (p.Arg212Cys)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA347001"}},"phenotypeFreeText":"facial palsy and mild hearing loss, optic atrophy, lower extremity pain, normal feeding","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/e52a921f-44f1-4372-a236-fffc8bcd68cd_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/29053833","allele":{"id":"https://genegraph.clinicalgenome.org/r/26649345-4e66-43f7-86c8-e1508cd510d7"},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}},{"id":"https://genegraph.clinicalgenome.org/r/e52a921f-44f1-4372-a236-fffc8bcd68cd","type":"EvidenceLine","calculatedScore":0.2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/e52a921f-44f1-4372-a236-fffc8bcd68cd_variant_evidence_item"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.2}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":0.2},{"id":"https://genegraph.clinicalgenome.org/r/0941040f-9f9f-40d0-b695-fb80f367ec4a_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/0941040f-9f9f-40d0-b695-fb80f367ec4a","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/29053833","rdfs:label":"Manole AP10 (English)","allele":[{"id":"https://genegraph.clinicalgenome.org/r/4c0baada-8043-4f8c-ae15-565c04372b36"},{"id":"https://genegraph.clinicalgenome.org/r/08b323b1-7899-4095-acd9-2ee34b57fcf6"}],"detectionMethod":"SLC52A1, SLC52A2 and SLC52A3","firstTestingMethod":"Sanger sequencing","phenotypeFreeText":"BVVL optic atrophy, hearing loss, sensorimotor neuropathy","secondTestingMethod":"PCR","sex":"Male","variant":[{"id":"https://genegraph.clinicalgenome.org/r/0c4d113d-0145-4b2d-9f5f-4abf1dd1624f_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/29053833","allele":{"id":"https://genegraph.clinicalgenome.org/r/08b323b1-7899-4095-acd9-2ee34b57fcf6"},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}},{"id":"https://genegraph.clinicalgenome.org/r/907c0d44-625d-40cb-9a46-d285c7e476e8_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/29053833","allele":{"id":"https://genegraph.clinicalgenome.org/r/4c0baada-8043-4f8c-ae15-565c04372b36"},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}]},{"id":"https://genegraph.clinicalgenome.org/r/907c0d44-625d-40cb-9a46-d285c7e476e8","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/907c0d44-625d-40cb-9a46-d285c7e476e8_variant_evidence_item"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/0c4d113d-0145-4b2d-9f5f-4abf1dd1624f","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/0c4d113d-0145-4b2d-9f5f-4abf1dd1624f_variant_evidence_item"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":0.2},{"id":"https://genegraph.clinicalgenome.org/r/3206beac-581e-4e31-bead-559f23d5a2b8_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/3206beac-581e-4e31-bead-559f23d5a2b8"},{"id":"https://genegraph.clinicalgenome.org/r/27ac6adc-23d2-4901-b141-8bf0fd8023db","type":"EvidenceLine","dc:description":"Downgraded for consanguinity and non-NMD variant.","calculatedScore":3.0,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/27ac6adc-23d2-4901-b141-8bf0fd8023db_variant_evidence_item"}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1.5}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/b38107b3-36b9-4abc-8e2d-655b5ed22229_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/b38107b3-36b9-4abc-8e2d-655b5ed22229","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/22824638","rdfs:label":"Ciccolella Patient 6","ageType":"AgeAtReport","ageUnit":"Years","ageValue":10,"allele":[{"id":"https://genegraph.clinicalgenome.org/r/0674e686-3bb0-435c-84be-5024707d1cb4","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_033409.4(SLC52A3):c.173T>A (p.Val58Asp)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA346973"}},{"id":"https://genegraph.clinicalgenome.org/r/4c0baada-8043-4f8c-ae15-565c04372b36"}],"detectionMethod":"PCR - Screened for SLC52A1, SLC52A3 and SLC52A2 variants\n\n","firstTestingMethod":"PCR","phenotypeFreeText":"Sensorineural hearing loss","sex":"Female","variant":[{"id":"https://genegraph.clinicalgenome.org/r/ff48daab-d9a6-48a3-b4dd-825aee797e37_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/22824638","allele":{"id":"https://genegraph.clinicalgenome.org/r/0674e686-3bb0-435c-84be-5024707d1cb4"},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}},{"id":"https://genegraph.clinicalgenome.org/r/2cdd023b-5732-4830-ac89-3a47d0b33374_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/22824638","allele":{"id":"https://genegraph.clinicalgenome.org/r/4c0baada-8043-4f8c-ae15-565c04372b36"},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}]},{"id":"https://genegraph.clinicalgenome.org/r/2cdd023b-5732-4830-ac89-3a47d0b33374","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/2cdd023b-5732-4830-ac89-3a47d0b33374_variant_evidence_item"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/ff48daab-d9a6-48a3-b4dd-825aee797e37","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/ff48daab-d9a6-48a3-b4dd-825aee797e37_variant_evidence_item"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":0.2},{"id":"https://genegraph.clinicalgenome.org/r/cf620d1a-1f86-40ce-861d-fec9f321f38f_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/cf620d1a-1f86-40ce-861d-fec9f321f38f"},{"id":"https://genegraph.clinicalgenome.org/r/552c2992-5138-41ba-a147-7cd9850651e6","type":"EvidenceLine","calculatedScore":0.2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/552c2992-5138-41ba-a147-7cd9850651e6_variant_evidence_item"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.2}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":0.2},{"id":"https://genegraph.clinicalgenome.org/r/dabe701d-2dbe-433d-bfcd-6e0ec69a8c1e_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/dabe701d-2dbe-433d-bfcd-6e0ec69a8c1e","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/20206331","rdfs:label":"Family 6 Case 8 (European)","ageType":"AgeAtOnset","ageUnit":"Months","ageValue":3,"allele":{"id":"https://genegraph.clinicalgenome.org/r/8a4d0789-d311-4515-a17a-dc6ce5a0fced","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_033409.4(SLC52A3):c.1371C>G (p.Phe457Leu)","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/210029"}},"detectionMethod":"SLC52A3 sequencing","firstTestingMethod":"PCR","phenotypeFreeText":"Breathing difficulties, weakness 3 months onset; deafness, respiratory compromise age 3 mo, general weakness, flaccid, died age 11 mo","sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/741f1254-4d3c-4ef2-befc-b2061f315821_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/20206331","allele":{"id":"https://genegraph.clinicalgenome.org/r/8a4d0789-d311-4515-a17a-dc6ce5a0fced"},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}},{"id":"https://genegraph.clinicalgenome.org/r/741f1254-4d3c-4ef2-befc-b2061f315821","type":"EvidenceLine","calculatedScore":0.2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/741f1254-4d3c-4ef2-befc-b2061f315821_variant_evidence_item"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.2}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":0.2}],"specifiedBy":"GeneValidityOverallGeneticEvidenceCriteria","strengthScore":12},{"id":"https://genegraph.clinicalgenome.org/r/b0ae82e2-4c39-45b2-ba2d-6fe2570dbcfc_experimental_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/b0ae82e2-4c39-45b2-ba2d-6fe2570dbcfc_functional_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/1f118bea-2663-469a-976b-723f7f48bc0a","type":"EvidenceLine","dc:description":"Upgraded due to study in humans, this should be the only expression points awarded because it is somewhat ubiquitously expressed. However, its presence in the heart, lung, and muscles are crucial for the BVVL phenotype.","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/866f738e-8e15-434b-a663-acdd614f7f58","type":"Finding","dc:description":"broad survey of the relative expression of Slc52a3 by quantitative RT-PCR indicated that transcripts were present in intestine and testis, but absent or rare in the brain, spinal cord, heart, lung, liver and musculature","dc:source":"https://pubmed.ncbi.nlm.nih.gov/26976849","rdfs:label":"Expresion of SLC52A3 in human and mouse tissues","demonstrates":{"id":"cg:GeneExpressionA"}}],"specifiedBy":"GeneValidityGeneExpressionCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/767d70a6-c57b-415c-a48e-e003d569d99a","type":"EvidenceLine","dc:description":"This study investigated the properties of the riboflavin uptake and how it is dictated by glycosylation. it also investigated different variants' impact on the uptake. (scored elsewhere)","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/fe970d00-e42b-4e80-9f81-c2cd2553733e","type":"Finding","dc:description":"The SCL52A3 transporter is involved in riboflavin uptake in the body. Individuals who have variants such as the Asn94 and Asn168 have been shown to have decreased riboflavin uptake which leads to a deficiency that causes BVVL.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/28637675","rdfs:label":"Riboflavin transport","demonstrates":{"id":"cg:BiochemicalFunctionB"}}],"specifiedBy":"GeneValidityBiochemicalFunctionCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityOverallFunctionalEvidenceCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/b0ae82e2-4c39-45b2-ba2d-6fe2570dbcfc_functional_alteration_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/56227e46-9afd-4ff5-a211-289345853d7c","type":"EvidenceLine","dc:description":"correlates to riboflavin deficiency phenotype that causes features rescued by supplementation","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/c7be255c-2cb8-492f-9f50-61eae64e3b2e","type":"FunctionalAlteration","dc:description":"Found decreased riboflavin uptake in the cell lines via H3 labeled assays. This explains the riboflavin deficiency in patients with variants in the gene.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/28637675","rdfs:label":"Mutation of the N-glycosylation sites Asn 94 and Asn168"}],"specifiedBy":"GeneValidityNonPatientCellFunctionalAlterationCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityOverallFunctionalAlterationEvidenceCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/b0ae82e2-4c39-45b2-ba2d-6fe2570dbcfc_model_rescue_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/cf4455bf-8b9f-4c21-bc51-9a1be7a2ac4c","type":"EvidenceLine","dc:description":"Several mouse models of BVVL have been phenotypically assessed and the mouse is considered a good model for the phenotype. (e.g. Intoh et al. 2016 26976849 ). Additionally, the supplementation of the riboflavin rescuing the phenotype provides further evidence for the impact of the gene. \nHowever the model was downgraded because it does not replicate either the hearing loss or muscle weakness associated with Brown-Vialetto-van Laere syndrome.","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/f848c830-c481-41cf-967d-4c40c692b34f","type":"Finding","dc:description":"Targeted disruption of the SLC52A3 gene causes death within 48 hours after birth. Lower body weight, normal organogenesis. Riboflavin supplementation in the knockout mice was found to increase birth weight and lifespan. These findings are consistent with the human phenotype.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/27272163","rdfs:label":"SLC52A3 -/-","demonstrates":{"id":"cg:ProteinAlterationDisruptsOrganismFunction"}}],"specifiedBy":"GeneValidityNonHumanModelOrganismCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/d3db88d5-ffd2-4ade-8e6e-66d53f2eb54c","type":"EvidenceLine","dc:description":"Downgraded for fly homolog of gene, but didn't do a complete downgrade because of the rescue of the phenotypes with riboflavin supplementation.","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/33a5db7f-8ba9-4874-9099-1f40a505932b","type":"Finding","dc:description":"The decreased respiratory activity and locomotive behavior in the flies is consistent with the overall phenotype seen in humans with BVVL. Additionally riboflavin supplementation rescuing the phenotype is consistent with human treatment","dc:source":"https://pubmed.ncbi.nlm.nih.gov/29053833","rdfs:label":"Drosophila \"drift\"  model","demonstrates":{"id":"cg:ProteinAlterationDisruptsOrganismFunction"}}],"specifiedBy":"GeneValidityNonHumanModelOrganismCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/86c2979d-bfde-449a-bdcd-9a2d35acbabd","type":"EvidenceLine","dc:description":"Already upgraded the Yoshimatsu mouse model by 0.5 points for replication in this paper.","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/437c631a-b3c7-43e6-8ea1-75efc957252b","type":"Finding","dc:description":"This study demonstrated the embryonic lethality of the SLC52A3 mouse model.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/26976849","rdfs:label":"SLC52A3 -/- mouse","demonstrates":{"id":"cg:ProteinAlterationDisruptsOrganismFunction"}}],"specifiedBy":"GeneValidityNonHumanModelOrganismCriteria","strengthScore":0}],"specifiedBy":"GeneValidityOverallModelAndRescueEvidenceCriteria","strengthScore":3}],"specifiedBy":"GeneValidityOverallExperimentalEvidenceCriteria","strengthScore":5}],"evidenceStrength":"Definitive","sequence":7047,"specifiedBy":"GeneValidityCriteria9","strengthScore":17,"subject":{"id":"https://genegraph.clinicalgenome.org/r/OGcn2nmOlMg","type":"GeneValidityProposition","disease":"obo:MONDO_0024537","gene":"hgnc:16187","modeOfInheritance":"obo:HP_0000007"},"version":"2.0","websiteLegacyID":"https://genegraph.clinicalgenome.org/r/assertion_b0ae82e2-4c39-45b2-ba2d-6fe2570dbcfc-","@context":{"@vocab":"https://genegraph.clinicalgenome.org/terms/","id":"@id","type":"@type","cg":"https://genegraph.clinicalgenome.org/terms/","dc":"http://purl.org/dc/terms/","obo":"http://purl.obolibrary.org/obo/","hgnc":"https://identifiers.org/hgnc:","rdfs":"http://www.w3.org/2000/01/rdf-schema#","cggv":"https://genegraph.clinicalgenome.org/r/gci/","evidenceStrength":{"@type":"@vocab"},"calculatedEvidenceStrength":{"@type":"@vocab"},"computedEvidenceStrength":{"@type":"@vocab"},"specifiedBy":{"@type":"@vocab"},"evidence":{"@container":"@set"},"disease":{"@type":"@vocab"},"gene":{"@type":"@vocab"},"phenotypes":{"@type":"@id"},"agent":{"@type":"@id"},"role":{"@type":"@vocab"},"modeOfInheritance":{"@type":"@vocab"},"sex":{"@type":"@vocab"},"direction":{"@type":"@vocab"},"ageType":{"@type":"@vocab"},"ageUnit":{"@type":"@vocab"},"dc:source":{"@type":"@id"},"curationReasons":{"@type":"@vocab","@container":"@set"},"GCISnapshot":{"@type":"@id"},"dc:isVersionOf":{"@type":"@id"},"websiteLegacyID":{"@type":"@id"}}}